C
JNJ icon

Cerebellum’s Johnson & Johnson JNJ Stock Holding History

Cerebellum’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,186
Closed -$166K – 483
2020
Q2 		$166K Buy
+1,186
New +$173K 0.12% 58
2019
Q1 		– Sell
-17
Closed -$2K – 493
2018
Q4 		$2K Hold
17
– – ﹤0.01% 437
2018
Q3 		$2K Sell
17
-5
-23% -$664 ﹤0.01% 405
2018
Q2 		$3K Sell
22
-404
-95% -$50.4K 0.01% 398
2018
Q1 		$55K Sell
426
-760
-64% -$103K 0.07% 397
2017
Q4 		$166K Buy
+1,186
New +$165K 0.12% 58

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cerebellum's JNJ Position: Q3 2020 in Review

Cerebellum sold out of Johnson & Johnson (JNJ) in Q3 2020, closing a stake of 1,186 shares — an estimated $166K sold.

Cerebellum first reported a position in JNJ in Q4 2017 and held it in 6 quarters. The position peaked at $166K in Q2 2020. 2,984 funds tracked by Wall St. Rank hold JNJ as of Q3 2020.

  • Cerebellum reported no remaining Johnson & Johnson position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 1,186 Johnson & Johnson shares in Q3 2020, an estimated $166K.
  • Cerebellum first reported a position in Johnson & Johnson in Q4 2017 and held it in 6 quarters.
  • Cerebellum's Johnson & Johnson position peaked at $166K in Q2 2020.
  • 2,984 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.